Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients
- 1 January 2005
- journal article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 45 (1), 162-166
- https://doi.org/10.1053/j.ajkd.2004.09.017
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patientJournal of Antimicrobial Chemotherapy, 2004
- Voriconazole, a novel wide‐spectrum triazole: oral pharmacokinetics and safetyBritish Journal of Clinical Pharmacology, 2003
- Effect of food on the pharmacokinetics of multiple‐dose oral voriconazoleBritish Journal of Clinical Pharmacology, 2003
- Development and Validation of a High-Performance Liquid Chromatography Assay for VoriconazoleAntimicrobial Agents and Chemotherapy, 2003
- Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation RegimensAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida sppAntimicrobial Agents and Chemotherapy, 2002
- Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodesAmerican Journal of Kidney Diseases, 1996
- Preliminary Safety Evaluation of Parenterally Administered Sulfoalkyl Ether β-Cyclodextrin DerivativesJournal of Pharmaceutical Sciences, 1995
- Biochemistry and molecular biology of the human CYP2C subfamilyPharmacogenetics, 1994
- Risk of peritonitis and technique failure by CAPD connection technique: A national studyKidney International, 1992